{"transactions":[{"id":927524,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T20:55:35.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":7.8,"value":780000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options will vest and be exercisable on the first date on which the average closing price (rounded to the nearest penny) of the Company's listed stock for the then previous forty five (45) calendar days is equal to or greater than the $24.00 Strike Price."}],"balance_after":774163,"derivative":{"exercise_price":7.8,"expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001628280-26-004381","document":"wk-form4_1769806532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004381/wk-form4_1769806532.xml","form_type":"4"}},{"id":927523,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T20:55:35.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":7.8,"value":780000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options will vest and be exercisable on the first date on which the average closing price (rounded to the nearest penny) of the Company's listed stock for the then previous forty five (45) calendar days is equal to or greater than the $16.00 Strike Price."}],"balance_after":674163,"derivative":{"exercise_price":7.8,"expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001628280-26-004381","document":"wk-form4_1769806532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004381/wk-form4_1769806532.xml","form_type":"4"}},{"id":927522,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T20:55:35.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":7.8,"value":1170000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest and be exercisable if (i) the Company achieves EBITDA of $35 million over any consecutive four quarter period  (based on the Company's fiscal year) or (ii) when $30 million of the Company's data revenue is recognized over any consecutive four quarter period (based on the Company's fiscal year)."}],"balance_after":574163,"derivative":{"exercise_price":7.8,"expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001628280-26-004381","document":"wk-form4_1769806532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004381/wk-form4_1769806532.xml","form_type":"4"}},{"id":927521,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T20:55:35.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":7.8,"value":487500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options will vest and be exercisable when $15 million of the Company's data revenue is recognized over any consecutive four quarter period (based on the Company's fiscal year)."}],"balance_after":424163,"derivative":{"exercise_price":7.8,"expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001628280-26-004381","document":"wk-form4_1769806532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004381/wk-form4_1769806532.xml","form_type":"4"}},{"id":927520,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T20:55:35.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":7.8,"value":487500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest and be exercisable if the Company achieves EBITDA of $25 million over any consecutive four quarter period (based on the Company's fiscal year)."}],"balance_after":361663,"derivative":{"exercise_price":7.8,"expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001628280-26-004381","document":"wk-form4_1769806532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004381/wk-form4_1769806532.xml","form_type":"4"}},{"id":927519,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T20:55:35.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":7.8,"value":1755000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable as follows: 25% will vest on the one-year anniversary of the grant date on July 16, 2026; the balance will vest ratably at a rate of 1/36th each month thereafter."}],"balance_after":299163,"derivative":{"exercise_price":7.8,"expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001628280-26-004381","document":"wk-form4_1769806532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004381/wk-form4_1769806532.xml","form_type":"4"}},{"id":927517,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T17:15:54.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":23030,"price":4.64,"value":106859.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively."}],"balance_after":74163,"derivative":{"exercise_price":4.64,"expiration_date":"2034-11-12","underlying":"Common Stock","underlying_shares":23030},"source":{"system":"sec-edgar","filing":"0001628280-26-004342","document":"wk-form4_1769793351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004342/wk-form4_1769793351.xml","form_type":"4"}},{"id":927516,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T17:15:54.000Z","date":"2023-11-03","kind":"grant","planned":false,"acquired":true,"shares":19070,"price":5.51,"value":105075.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 3, 2023,  February 3, 2024, May 3, 2024 and August 3, 2024, respectively."}],"balance_after":51133,"derivative":{"exercise_price":5.51,"expiration_date":"2033-11-03","underlying":"Common Stock","underlying_shares":19070},"source":{"system":"sec-edgar","filing":"0001628280-26-004342","document":"wk-form4_1769793351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004342/wk-form4_1769793351.xml","form_type":"4"}},{"id":927515,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T17:15:54.000Z","date":"2022-11-01","kind":"grant","planned":false,"acquired":true,"shares":14130,"price":7,"value":98910.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2022, February 1, 2023, May 1, 2023 and August 1, 2023, respectively."}],"balance_after":32063,"derivative":{"exercise_price":7,"expiration_date":"2032-11-01","underlying":"Common Stock","underlying_shares":14130},"source":{"system":"sec-edgar","filing":"0001628280-26-004342","document":"wk-form4_1769793351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004342/wk-form4_1769793351.xml","form_type":"4"}},{"id":927514,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T17:15:54.000Z","date":"2021-11-05","kind":"grant","planned":false,"acquired":true,"shares":9901,"price":10.1,"value":100000.1,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2021, February 5, 2022, May 5, 2022 and August 5, 2022, respectively."}],"balance_after":17933,"derivative":{"exercise_price":10.1,"expiration_date":"2031-11-05","underlying":"Common Stock","underlying_shares":9901},"source":{"system":"sec-edgar","filing":"0001628280-26-004342","document":"wk-form4_1769793351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004342/wk-form4_1769793351.xml","form_type":"4"}},{"id":1005430,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73486,"kind":"person","name":"Breitfeld Philip P.","position":1,"cik":"0001690133","reported_name":"Breitfeld Philip P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-11-07T17:14:38.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":13790,"price":6.8,"value":93772.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively."}],"balance_after":13790,"derivative":{"exercise_price":6.8,"expiration_date":"2035-11-05","underlying":"Common Stock","underlying_shares":13790},"source":{"system":"sec-edgar","filing":"0001628280-25-050522","document":"wk-form4_1762535675.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828025050522/wk-form4_1762535675.xml","form_type":"4"}},{"id":1005429,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-11-07T16:57:25.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":21216,"price":6.8,"value":144268.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively."}],"balance_after":21216,"derivative":{"exercise_price":6.8,"expiration_date":"2035-11-05","underlying":"Common Stock","underlying_shares":21216},"source":{"system":"sec-edgar","filing":"0001628280-25-050514","document":"wk-form4_1762534641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828025050514/wk-form4_1762534641.xml","form_type":"4"}},{"id":1005427,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-11-07T16:18:38.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":13790,"price":6.8,"value":93772.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively."}],"balance_after":13790,"derivative":{"exercise_price":6.8,"expiration_date":"2035-11-05","underlying":"Common Stock","underlying_shares":13790},"source":{"system":"sec-edgar","filing":"0001628280-25-050491","document":"wk-form4_1762532316.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828025050491/wk-form4_1762532316.xml","form_type":"4"}},{"id":1005426,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":37734,"kind":"person","name":"TOBIN SCOTT R","position":1,"cik":"0001199926","reported_name":"TOBIN SCOTT R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-11-07T16:00:01.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":25460,"price":6.8,"value":173128.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively."}],"balance_after":25460,"derivative":{"exercise_price":6.8,"expiration_date":"2035-11-05","underlying":"Common Stock","underlying_shares":25460},"source":{"system":"sec-edgar","filing":"0001628280-25-050481","document":"wk-form4_1762531198.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828025050481/wk-form4_1762531198.xml","form_type":"4"}},{"id":1005425,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-11-07T15:26:59.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":21216,"price":6.8,"value":144268.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively."}],"balance_after":21216,"derivative":{"exercise_price":6.8,"expiration_date":"2035-11-05","underlying":"Common Stock","underlying_shares":21216},"source":{"system":"sec-edgar","filing":"0001628280-25-050467","document":"wk-form4_1762529216.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828025050467/wk-form4_1762529216.xml","form_type":"4"}},{"id":1006306,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-11-06T16:19:39.000Z","date":"2025-10-30","kind":"exercise","planned":false,"acquired":false,"shares":94405,"price":2.1,"value":198250.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"70,804 options were immediately exercisable on grant date of July 19, 2016, with the remaining options vesting and available to exercise on October 31, 2016."}],"balance_after":0,"derivative":{"exercise_price":2.1,"expiration_date":"2025-11-01","underlying":"Common Stock","underlying_shares":94405},"source":{"system":"sec-edgar","filing":"0001628280-25-049954","document":"wk-form4_1762445975.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828025049954/wk-form4_1762445975.xml","form_type":"4"}},{"id":1006305,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-06T16:19:39.000Z","date":"2025-10-30","kind":"exercise","planned":false,"acquired":true,"shares":94405,"price":2.1,"value":198250.5,"ownership":{"direct":true},"balance_after":1056539,"source":{"system":"sec-edgar","filing":"0001628280-25-049954","document":"wk-form4_1762445975.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828025049954/wk-form4_1762445975.xml","form_type":"4"}},{"id":1185370,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73486,"kind":"person","name":"Breitfeld Philip P.","position":1,"cik":"0001690133","reported_name":"Breitfeld Philip P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T20:20:36.000Z","date":"2025-03-25","kind":"other","planned":false,"acquired":false,"shares":4150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were transferred to a donor-advised charitable trust fund; upon receipt of the shares, the fund sold the shares."}],"balance_after":5717,"source":{"system":"sec-edgar","filing":"0001628280-25-016197","document":"wk-form4_1743625230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828025016197/wk-form4_1743625230.xml","form_type":"4"}},{"id":1362822,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73486,"kind":"person","name":"Breitfeld Philip P.","position":1,"cik":"0001690133","reported_name":"Breitfeld Philip P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-11-18T17:14:09.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":18715,"price":4.64,"value":86837.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively."}],"balance_after":18715,"derivative":{"exercise_price":4.64,"expiration_date":"2034-11-12","underlying":"Common Stock","underlying_shares":18715},"source":{"system":"sec-edgar","filing":"0001628280-24-048217","document":"wk-form4_1731950043.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024048217/wk-form4_1731950043.xml","form_type":"4"}},{"id":1362819,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-11-18T16:47:41.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":21880,"price":4.64,"value":101523.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively."}],"balance_after":21880,"derivative":{"exercise_price":4.64,"expiration_date":"2034-11-12","underlying":"Common Stock","underlying_shares":21880},"source":{"system":"sec-edgar","filing":"0001628280-24-048211","document":"wk-form4_1731948454.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024048211/wk-form4_1731948454.xml","form_type":"4"}},{"id":1362820,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-11-18T16:18:53.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":21590,"price":4.64,"value":100177.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively."}],"balance_after":21590,"derivative":{"exercise_price":4.64,"expiration_date":"2034-11-12","underlying":"Common Stock","underlying_shares":21590},"source":{"system":"sec-edgar","filing":"0001628280-24-048205","document":"wk-form4_1731946727.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024048205/wk-form4_1731946727.xml","form_type":"4"}},{"id":1362818,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":37734,"kind":"person","name":"TOBIN SCOTT R","position":1,"cik":"0001199926","reported_name":"TOBIN SCOTT R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-11-18T16:09:05.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":34550,"price":4.64,"value":160312.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively."}],"balance_after":34550,"derivative":{"exercise_price":4.64,"expiration_date":"2034-11-12","underlying":"Common Stock","underlying_shares":34550},"source":{"system":"sec-edgar","filing":"0001628280-24-048196","document":"wk-form4_1731946138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024048196/wk-form4_1731946138.xml","form_type":"4"}},{"id":1362811,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-11-18T15:59:51.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":43190,"price":4.64,"value":200401.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively."}],"balance_after":43190,"derivative":{"exercise_price":4.64,"expiration_date":"2034-11-12","underlying":"Common Stock","underlying_shares":43190},"source":{"system":"sec-edgar","filing":"0001628280-24-048193","document":"wk-form4_1731945585.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024048193/wk-form4_1731945585.xml","form_type":"4"}},{"id":1378555,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-11-01T13:04:36.000Z","date":"2024-10-31","kind":"exercise","planned":false,"acquired":false,"shares":16667,"price":5.43,"value":90501.81,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"4,167 options were immediately exercisable on November 4, 2019 with the remaining options vesting and available to exercise on  February 4, 2020, May 4, 2020 and August 4, 2020."}],"balance_after":0,"derivative":{"exercise_price":5.43,"expiration_date":"2024-11-03","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001628280-24-044663","document":"wk-form4_1730466270.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024044663/wk-form4_1730466270.xml","form_type":"4"}},{"id":1378554,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-11-01T13:04:36.000Z","date":"2024-10-31","kind":"exercise","planned":false,"acquired":false,"shares":88470,"price":2.1,"value":185787.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were immediately exercisable upon grant on July 19, 2016."}],"balance_after":0,"derivative":{"exercise_price":2.1,"expiration_date":"2024-11-01","underlying":"Common Stock","underlying_shares":88470},"source":{"system":"sec-edgar","filing":"0001628280-24-044663","document":"wk-form4_1730466270.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024044663/wk-form4_1730466270.xml","form_type":"4"}},{"id":1378553,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-01T13:04:36.000Z","date":"2024-10-31","kind":"exercise","planned":false,"acquired":true,"shares":16667,"price":5.43,"value":90501.81,"ownership":{"direct":true},"balance_after":962134,"source":{"system":"sec-edgar","filing":"0001628280-24-044663","document":"wk-form4_1730466270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024044663/wk-form4_1730466270.xml","form_type":"4"}},{"id":1378552,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-01T13:04:36.000Z","date":"2024-10-31","kind":"exercise","planned":false,"acquired":true,"shares":88470,"price":2.1,"value":185787.0,"ownership":{"direct":true},"balance_after":945467,"source":{"system":"sec-edgar","filing":"0001628280-24-044663","document":"wk-form4_1730466270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024044663/wk-form4_1730466270.xml","form_type":"4"}},{"id":1557144,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":92505,"kind":"person","name":"Davis Brady","position":1,"cik":"0002002615","reported_name":"Davis Brady","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Option to purchase Common Stock","published_at":"2024-04-01T19:18:24.000Z","date":"2023-10-09","kind":"grant","planned":false,"acquired":true,"shares":68000,"price":6.5,"value":442000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest over a four year period starting from the one year anniversary of the achievement of specific performance criteria and are exercisable over a ten year period."}],"balance_after":210500,"derivative":{"exercise_price":6.5,"expiration_date":"2033-10-09","underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001628280-24-013993","document":"wk-form4_1711999092.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024013993/wk-form4_1711999092.xml","form_type":"4"}},{"id":1557143,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":92505,"kind":"person","name":"Davis Brady","position":1,"cik":"0002002615","reported_name":"Davis Brady","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Option to purchase Common Stock","published_at":"2024-04-01T19:18:24.000Z","date":"2023-10-09","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":6.5,"value":48750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest fully (100%) on the one year anniversary of the date of grant and are exercisable over a ten year period, with vesting to occur on October 9, 2024."}],"balance_after":142500,"derivative":{"exercise_price":6.5,"expiration_date":"2033-10-09","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001628280-24-013993","document":"wk-form4_1711999092.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024013993/wk-form4_1711999092.xml","form_type":"4"}},{"id":1557142,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":92505,"kind":"person","name":"Davis Brady","position":1,"cik":"0002002615","reported_name":"Davis Brady","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Option to purchase Common Stock","published_at":"2024-04-01T19:18:24.000Z","date":"2023-10-09","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":6.5,"value":877500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a four year period and are exercisable over a ten year period, with vesting to occur on October 9, 2024, October 9, 2025, October 9, 2026 and October 9, 2027, respectively."}],"balance_after":135000,"derivative":{"exercise_price":6.5,"expiration_date":"2033-10-09","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001628280-24-013993","document":"wk-form4_1711999092.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024013993/wk-form4_1711999092.xml","form_type":"4"}},{"id":1679548,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-16T16:45:44.000Z","date":"2024-01-12","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.5,"value":6500.0,"ownership":{"direct":true},"balance_after":198625,"source":{"system":"sec-edgar","filing":"0001628280-24-001334","document":"wk-form4_1705423535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024001334/wk-form4_1705423535.xml","form_type":"4"}},{"id":1680382,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-12T17:47:07.000Z","date":"2024-01-11","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":6.27,"value":12540.0,"ownership":{"direct":true},"balance_after":197625,"source":{"system":"sec-edgar","filing":"0001628280-24-001231","document":"wk-form4_1705081618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024001231/wk-form4_1705081618.xml","form_type":"4"}},{"id":1681150,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-11T15:57:35.000Z","date":"2024-01-10","kind":"purchase","planned":false,"acquired":true,"shares":2944,"price":6.31,"value":18576.64,"ownership":{"direct":true},"balance_after":195625,"source":{"system":"sec-edgar","filing":"0001628280-24-001118","document":"wk-form4_1704988646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024001118/wk-form4_1704988646.xml","form_type":"4"}},{"id":1682049,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-10T13:57:40.000Z","date":"2024-01-09","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":6.25,"value":18750.0,"ownership":{"direct":true},"balance_after":192681,"source":{"system":"sec-edgar","filing":"0001628280-24-001002","document":"wk-form4_1704895046.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024001002/wk-form4_1704895046.xml","form_type":"4"}},{"id":1683391,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-09T14:08:15.000Z","date":"2024-01-08","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.15,"value":6150.0,"ownership":{"direct":true},"balance_after":189681,"source":{"system":"sec-edgar","filing":"0001628280-24-000896","document":"wk-form4_1704809286.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024000896/wk-form4_1704809286.xml","form_type":"4"}},{"id":1684873,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-08T20:11:57.000Z","date":"2024-01-05","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":6.09,"value":12180.0,"ownership":{"direct":true},"balance_after":188681,"source":{"system":"sec-edgar","filing":"0001628280-24-000825","document":"wk-form4_1704744709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024000825/wk-form4_1704744709.xml","form_type":"4"}},{"id":1684872,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-08T19:54:56.000Z","date":"2024-01-04","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":6.12,"value":18360.0,"ownership":{"direct":true},"balance_after":186681,"source":{"system":"sec-edgar","filing":"0001628280-24-000820","document":"wk-form4_1704743687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024000820/wk-form4_1704743687.xml","form_type":"4"}},{"id":1686602,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-01-05T20:52:00.000Z","date":"2023-10-17","kind":"exercise","planned":false,"acquired":false,"shares":14552,"price":2.1,"value":30559.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were immediately exercisable upon grant on July 19, 2016."}],"balance_after":0,"derivative":{"exercise_price":2.1,"exercise_date":"2016-07-19","expiration_date":"2023-11-05","underlying":"Common Stock","underlying_shares":14552},"source":{"system":"sec-edgar","filing":"0001628280-24-000639","document":"wk-form4_1704487909.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024000639/wk-form4_1704487909.xml","form_type":"4"}},{"id":1686601,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-01-05T20:52:00.000Z","date":"2023-10-17","kind":"exercise","planned":false,"acquired":false,"shares":100000,"price":2.1,"value":210000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"84,600 options were immediately exercisable upon grant on July 19, 2016 with the remaining options vesting on August 5, 2016 and November 5, 2016."}],"balance_after":0,"derivative":{"exercise_price":2.1,"exercise_date":"2016-07-19","expiration_date":"2023-11-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001628280-24-000639","document":"wk-form4_1704487909.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024000639/wk-form4_1704487909.xml","form_type":"4"}},{"id":1686600,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-05T20:52:00.000Z","date":"2023-10-17","kind":"exercise","planned":false,"acquired":true,"shares":114552,"price":2.1,"value":240559.2,"ownership":{"direct":true},"balance_after":856997,"source":{"system":"sec-edgar","filing":"0001628280-24-000639","document":"wk-form4_1704487909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024000639/wk-form4_1704487909.xml","form_type":"4"}},{"id":1689902,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T18:37:03.000Z","date":"2024-01-03","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":5.83,"value":2915.0,"ownership":{"direct":true},"balance_after":183681,"source":{"system":"sec-edgar","filing":"0001628280-24-000388","document":"wk-form4_1704393413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024000388/wk-form4_1704393413.xml","form_type":"4"}},{"id":1700480,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-26T16:48:13.000Z","date":"2023-12-21","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":4.92,"value":12300.0,"ownership":{"direct":true},"balance_after":183181,"source":{"system":"sec-edgar","filing":"0001628280-23-042662","document":"wk-form4_1703609285.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023042662/wk-form4_1703609285.xml","form_type":"4"}},{"id":1702841,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-21T19:31:13.000Z","date":"2023-12-20","kind":"purchase","planned":false,"acquired":true,"shares":2100,"price":4.82,"value":10122.0,"ownership":{"direct":true},"balance_after":180681,"source":{"system":"sec-edgar","filing":"0001628280-23-042467","document":"wk-form4_1703187064.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023042467/wk-form4_1703187064.xml","form_type":"4"}},{"id":1703839,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-20T14:48:53.000Z","date":"2023-12-19","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.75,"value":23750.0,"ownership":{"direct":true},"balance_after":178581,"source":{"system":"sec-edgar","filing":"0001628280-23-042096","document":"wk-form4_1703083724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023042096/wk-form4_1703083724.xml","form_type":"4"}},{"id":1748204,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":37734,"kind":"person","name":"TOBIN SCOTT R","position":1,"cik":"0001199926","reported_name":"TOBIN SCOTT R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-11-07T17:00:02.000Z","date":"2023-11-03","kind":"grant","planned":false,"acquired":true,"shares":28600,"price":5.51,"value":157586.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively."}],"balance_after":28600,"derivative":{"exercise_price":5.51,"expiration_date":"2033-11-03","underlying":"Common Stock","underlying_shares":28600},"source":{"system":"sec-edgar","filing":"0001628280-23-037251","document":"wk-form4_1699376392.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023037251/wk-form4_1699376392.xml","form_type":"4"}},{"id":1748203,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-11-07T16:59:10.000Z","date":"2023-11-03","kind":"grant","planned":false,"acquired":true,"shares":35750,"price":5.51,"value":196982.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively."}],"balance_after":35750,"derivative":{"exercise_price":5.51,"expiration_date":"2033-11-03","underlying":"Common Stock","underlying_shares":35750},"source":{"system":"sec-edgar","filing":"0001628280-23-037250","document":"wk-form4_1699376342.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023037250/wk-form4_1699376342.xml","form_type":"4"}},{"id":1748202,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-11-07T16:58:37.000Z","date":"2023-11-03","kind":"grant","planned":false,"acquired":true,"shares":26220,"price":5.51,"value":144472.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively."}],"balance_after":26220,"derivative":{"exercise_price":5.51,"expiration_date":"2033-11-03","underlying":"Common Stock","underlying_shares":26220},"source":{"system":"sec-edgar","filing":"0001628280-23-037249","document":"wk-form4_1699376309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023037249/wk-form4_1699376309.xml","form_type":"4"}},{"id":1748201,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-11-07T16:57:48.000Z","date":"2023-11-03","kind":"grant","planned":false,"acquired":true,"shares":15495,"price":5.51,"value":85377.45,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively."}],"balance_after":15495,"derivative":{"exercise_price":5.51,"expiration_date":"2033-11-03","underlying":"Common Stock","underlying_shares":15495},"source":{"system":"sec-edgar","filing":"0001628280-23-037248","document":"wk-form4_1699376259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023037248/wk-form4_1699376259.xml","form_type":"4"}},{"id":1748200,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73486,"kind":"person","name":"Breitfeld Philip P.","position":1,"cik":"0001690133","reported_name":"Breitfeld Philip P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-11-07T16:57:00.000Z","date":"2023-11-03","kind":"grant","planned":false,"acquired":true,"shares":15495,"price":5.51,"value":85377.45,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively."}],"balance_after":15495,"derivative":{"exercise_price":5.51,"expiration_date":"2033-11-03","underlying":"Common Stock","underlying_shares":15495},"source":{"system":"sec-edgar","filing":"0001628280-23-037245","document":"wk-form4_1699376211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023037245/wk-form4_1699376211.xml","form_type":"4"}},{"id":1760252,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T13:53:56.000Z","date":"2023-09-29","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":6.16,"value":24640.0,"ownership":{"direct":true},"balance_after":173581,"source":{"system":"sec-edgar","filing":"0001628280-23-034409","document":"wk-form4_1697464428.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023034409/wk-form4_1697464428.xml","form_type":"4"}},{"id":1760251,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T13:52:39.000Z","date":"2023-09-28","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":6.22,"value":31100.0,"ownership":{"direct":true},"balance_after":169581,"source":{"system":"sec-edgar","filing":"0001628280-23-034407","document":"wk-form4_1697464350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023034407/wk-form4_1697464350.xml","form_type":"4"}},{"id":1760250,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T13:51:00.000Z","date":"2023-09-27","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":5.95,"value":8925.0,"ownership":{"direct":true},"balance_after":164581,"source":{"system":"sec-edgar","filing":"0001628280-23-034405","document":"wk-form4_1697464252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023034405/wk-form4_1697464252.xml","form_type":"4"}},{"id":1760874,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-13T16:48:11.000Z","date":"2023-10-11","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":6.4,"value":32000.0,"ownership":{"direct":true},"balance_after":163081,"source":{"system":"sec-edgar","filing":"0001628280-23-034348","document":"wk-form4_1697215682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023034348/wk-form4_1697215682.xml","form_type":"4"}},{"id":1762207,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-11T13:45:07.000Z","date":"2023-10-10","kind":"purchase","planned":false,"acquired":true,"shares":1100,"price":6.41,"value":7051.0,"ownership":{"direct":true},"balance_after":158081,"source":{"system":"sec-edgar","filing":"0001628280-23-034231","document":"wk-form4_1697031899.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023034231/wk-form4_1697031899.xml","form_type":"4"}},{"id":1763096,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-10T14:02:13.000Z","date":"2023-10-06","kind":"purchase","planned":false,"acquired":true,"shares":1530,"price":6.48,"value":9914.4,"ownership":{"direct":true},"balance_after":156981,"source":{"system":"sec-edgar","filing":"0001628280-23-034119","document":"wk-form4_1696946525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023034119/wk-form4_1696946525.xml","form_type":"4"}},{"id":1764044,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-06T11:10:55.000Z","date":"2023-10-05","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":6.47,"value":12940.0,"ownership":{"direct":true},"balance_after":155451,"source":{"system":"sec-edgar","filing":"0001628280-23-034004","document":"wf-form4_169659064199177.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023034004/wf-form4_169659064199177.xml","form_type":"4"}},{"id":1766141,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-04T21:31:08.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":6.3,"value":15750.0,"ownership":{"direct":true},"balance_after":148451,"source":{"system":"sec-edgar","filing":"0001628280-23-033843","document":"wf-form4_169645505352839.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023033843/wf-form4_169645505352839.xml","form_type":"4"}},{"id":1766140,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-04T21:30:36.000Z","date":"2023-10-04","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":6.4,"value":32000.0,"ownership":{"direct":true},"balance_after":153451,"source":{"system":"sec-edgar","filing":"0001628280-23-033842","document":"wf-form4_169645502108268.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023033842/wf-form4_169645502108268.xml","form_type":"4"}},{"id":1772963,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-27T13:56:59.000Z","date":"2023-09-26","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":5.65,"value":28250.0,"ownership":{"direct":true},"balance_after":145951,"source":{"system":"sec-edgar","filing":"0001628280-23-033077","document":"wf-form4_169582300558310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023033077/wf-form4_169582300558310.xml","form_type":"4"}},{"id":1774313,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-25T19:00:00.000Z","date":"2023-09-19","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":5.28,"value":26400.0,"ownership":{"direct":true},"balance_after":128121,"source":{"system":"sec-edgar","filing":"0001628280-23-032920","document":"wf-form4_169566838737069.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023032920/wf-form4_169566838737069.xml","form_type":"4"}},{"id":1774312,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-25T18:59:45.000Z","date":"2023-09-20","kind":"purchase","planned":false,"acquired":true,"shares":4018,"price":5.51,"value":22139.18,"ownership":{"direct":true},"balance_after":132139,"source":{"system":"sec-edgar","filing":"0001628280-23-032919","document":"wf-form4_169566837025005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023032919/wf-form4_169566837025005.xml","form_type":"4"}},{"id":1774311,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-25T18:59:26.000Z","date":"2023-09-21","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":5.51,"value":27550.0,"ownership":{"direct":true},"balance_after":137139,"source":{"system":"sec-edgar","filing":"0001628280-23-032918","document":"wf-form4_169566835107905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023032918/wf-form4_169566835107905.xml","form_type":"4"}},{"id":1774310,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-25T18:59:08.000Z","date":"2023-09-22","kind":"purchase","planned":false,"acquired":true,"shares":3812,"price":5.5,"value":20966.0,"ownership":{"direct":true},"balance_after":140951,"source":{"system":"sec-edgar","filing":"0001628280-23-032917","document":"wf-form4_169566833604307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023032917/wf-form4_169566833604307.xml","form_type":"4"}},{"id":1804749,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-08-17T16:10:05.000Z","date":"2022-11-01","kind":"grant","planned":false,"acquired":true,"shares":26500,"price":7,"value":185500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 1, 2022,  February 1, 2023, May 1, 2023 and August 1, 2023, respectively."}],"balance_after":26500,"derivative":{"exercise_price":7,"expiration_date":"2032-11-01","underlying":"Common Stock","underlying_shares":26500},"source":{"system":"sec-edgar","filing":"0001628280-23-029779","document":"wf-form4_169228859069507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023029779/wf-form4_169228859069507.xml","form_type":"4"}},{"id":1804748,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73486,"kind":"person","name":"Breitfeld Philip P.","position":1,"cik":"0001690133","reported_name":"Breitfeld Philip P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-08-17T16:09:10.000Z","date":"2022-11-01","kind":"grant","planned":false,"acquired":true,"shares":11480,"price":7,"value":80360.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 1, 2022,  February 1, 2023, May 1, 2023 and August 1,2023, respectively."}],"balance_after":11480,"derivative":{"exercise_price":7,"expiration_date":"2032-11-01","underlying":"Common Stock","underlying_shares":11480},"source":{"system":"sec-edgar","filing":"0001628280-23-029778","document":"wf-form4_169228853672738.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023029778/wf-form4_169228853672738.xml","form_type":"4"}},{"id":1804747,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-08-17T16:07:58.000Z","date":"2022-11-01","kind":"grant","planned":false,"acquired":true,"shares":19430,"price":7,"value":136010.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 1, 2022,  February 1, 2023, May 1, 2023 and August 1, 2023, respectively."}],"balance_after":19430,"derivative":{"exercise_price":7,"expiration_date":"2032-11-01","underlying":"Common Stock","underlying_shares":19430},"source":{"system":"sec-edgar","filing":"0001628280-23-029777","document":"wf-form4_169228846413492.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023029777/wf-form4_169228846413492.xml","form_type":"4"}},{"id":1804746,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-08-17T16:05:50.000Z","date":"2022-11-01","kind":"grant","planned":false,"acquired":true,"shares":11480,"price":7,"value":80360.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 1, 2022,  February 1, 2023, May 1, 2023 and August 1, 2023, respectively."}],"balance_after":11480,"derivative":{"exercise_price":7,"expiration_date":"2032-11-01","underlying":"Common Stock","underlying_shares":11480},"source":{"system":"sec-edgar","filing":"0001628280-23-029776","document":"wf-form4_169228834017538.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023029776/wf-form4_169228834017538.xml","form_type":"4"}},{"id":1804745,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":37734,"kind":"person","name":"TOBIN SCOTT R","position":1,"cik":"0001199926","reported_name":"TOBIN SCOTT R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-08-17T16:04:11.000Z","date":"2022-11-01","kind":"grant","planned":false,"acquired":true,"shares":21200,"price":7,"value":148400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 1, 2022,  February 1, 2023, May 1, 2023 and August 1, 2023, respectively."}],"balance_after":21200,"derivative":{"exercise_price":7,"expiration_date":"2032-11-01","underlying":"Common Stock","underlying_shares":21200},"source":{"system":"sec-edgar","filing":"0001628280-23-029775","document":"wf-form4_169228823891977.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023029775/wf-form4_169228823891977.xml","form_type":"4"}},{"id":1943841,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":115345,"kind":"person","name":"Morris Ronnie","position":1,"cik":"0001504443","reported_name":"Morris Ronnie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-03-21T16:30:22.000Z","date":"2023-03-17","kind":"purchase","planned":false,"acquired":true,"shares":12382,"price":4.0356,"value":49968.7992,"ownership":{"direct":true},"balance_after":858878,"source":{"system":"sec-edgar","filing":"0001628280-23-008699","document":"wf-form4_167941620961163.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023008699/wf-form4_167941620961163.xml","form_type":"4"}},{"id":2134341,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2022-10-20T17:26:54.000Z","date":"2022-10-19","kind":"exercise","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018, respectively."}],"balance_after":0,"derivative":{"exercise_price":3.21,"expiration_date":"2022-10-31","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001628280-22-026743","document":"wf-form4_166628679804291.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828022026743/wf-form4_166628679804291.xml","form_type":"4"}},{"id":2134340,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-20T17:26:54.000Z","date":"2022-10-19","kind":"exercise","acquired":true,"shares":16667,"price":3.21,"value":53501.07,"ownership":{"direct":true},"balance_after":1460595,"source":{"system":"sec-edgar","filing":"0001628280-22-026743","document":"wf-form4_166628679804291.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828022026743/wf-form4_166628679804291.xml","form_type":"4"}},{"id":2137355,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2022-10-14T18:27:02.000Z","date":"2022-10-12","kind":"exercise","acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018"}],"balance_after":0,"derivative":{"exercise_price":3.21,"expiration_date":"2022-10-31","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001628280-22-026400","document":"wf-form4_166577200797332.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828022026400/wf-form4_166577200797332.xml","form_type":"4"}},{"id":2137354,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-14T18:27:02.000Z","date":"2022-10-12","kind":"tax_withholding","acquired":false,"shares":3562,"price":7.51,"value":26750.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"net exercise\" of outstanding stock opitons. These shares were witheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, common stock on October 12, 2022."}],"balance_after":767043,"source":{"system":"sec-edgar","filing":"0001628280-22-026400","document":"wf-form4_166577200797332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828022026400/wf-form4_166577200797332.xml","form_type":"4"}},{"id":2137353,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-14T18:27:02.000Z","date":"2022-10-12","kind":"exercise","acquired":true,"shares":8333,"price":3.21,"value":26748.93,"ownership":{"direct":true},"balance_after":770605,"source":{"system":"sec-edgar","filing":"0001628280-22-026400","document":"wf-form4_166577200797332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828022026400/wf-form4_166577200797332.xml","form_type":"4"}},{"id":2137377,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73486,"kind":"person","name":"Breitfeld Philip P.","position":1,"cik":"0001690133","reported_name":"Breitfeld Philip P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2022-10-14T18:25:29.000Z","date":"2022-10-12","kind":"exercise","acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018"}],"balance_after":0,"derivative":{"exercise_price":3.21,"expiration_date":"2022-10-31","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001628280-22-026398","document":"wf-form4_166577191015059.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828022026398/wf-form4_166577191015059.xml","form_type":"4"}},{"id":2137376,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73486,"kind":"person","name":"Breitfeld Philip P.","position":1,"cik":"0001690133","reported_name":"Breitfeld Philip P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-14T18:25:29.000Z","date":"2022-10-12","kind":"tax_withholding","acquired":false,"shares":3562,"price":7.51,"value":26750.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"net exercise\" of outstanding stock opitons. These shares were witheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, common stock on October 12, 2022."}],"balance_after":14638,"source":{"system":"sec-edgar","filing":"0001628280-22-026398","document":"wf-form4_166577191015059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828022026398/wf-form4_166577191015059.xml","form_type":"4"}},{"id":2137375,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73486,"kind":"person","name":"Breitfeld Philip P.","position":1,"cik":"0001690133","reported_name":"Breitfeld Philip P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-14T18:25:29.000Z","date":"2022-10-12","kind":"exercise","acquired":true,"shares":8333,"price":3.21,"value":26748.93,"ownership":{"direct":true},"balance_after":18200,"source":{"system":"sec-edgar","filing":"0001628280-22-026398","document":"wf-form4_166577191015059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828022026398/wf-form4_166577191015059.xml","form_type":"4"}},{"id":2137954,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":37734,"kind":"person","name":"TOBIN SCOTT R","position":1,"cik":"0001199926","reported_name":"TOBIN SCOTT R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-10-13T13:00:26.000Z","date":"2022-10-12","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested"}],"balance_after":0,"derivative":{"exercise_price":3.21,"expiration_date":"2022-10-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-22-010488","document":"form4-10132022_061018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000141588922010488/form4-10132022_061018.xml","form_type":"4"}},{"id":2137953,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":37734,"kind":"person","name":"TOBIN SCOTT R","position":1,"cik":"0001199926","reported_name":"TOBIN SCOTT R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-13T13:00:26.000Z","date":"2022-10-12","kind":"exercise","acquired":true,"shares":10000,"price":3.21,"value":32100.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001415889-22-010488","document":"form4-10132022_061018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000141588922010488/form4-10132022_061018.xml","form_type":"4"}},{"id":2520643,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-11-09T22:32:44.000Z","date":"2021-11-05","kind":"grant","acquired":true,"shares":8045,"price":10.1,"value":81254.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2021,  February 5, 2022, May 5, 2022 and August 5, 2022, respectively."}],"balance_after":8045,"derivative":{"exercise_price":10.1,"expiration_date":"2031-11-05","underlying":"Common Stock","underlying_shares":8045},"source":{"system":"sec-edgar","filing":"0001628280-21-022608","document":"wf-form4_163649714939624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021022608/wf-form4_163649714939624.xml","form_type":"4"}},{"id":2520644,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-11-09T22:31:59.000Z","date":"2021-11-05","kind":"grant","acquired":true,"shares":13614,"price":10.1,"value":137501.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2021,  February 5, 2022, May 5, 2022 and August 5, 2022, respectively."}],"balance_after":13614,"derivative":{"exercise_price":10.1,"expiration_date":"2031-11-05","underlying":"Common Stock","underlying_shares":13614},"source":{"system":"sec-edgar","filing":"0001628280-21-022606","document":"wf-form4_163649710448444.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021022606/wf-form4_163649710448444.xml","form_type":"4"}},{"id":2520642,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73486,"kind":"person","name":"Breitfeld Philip P.","position":1,"cik":"0001690133","reported_name":"Breitfeld Philip P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-11-09T22:31:23.000Z","date":"2021-11-05","kind":"grant","acquired":true,"shares":8045,"price":10.1,"value":81254.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2021,  February 5, 2022, May 5, 2022 and August 5,2022, respectively."}],"balance_after":8045,"derivative":{"exercise_price":10.1,"expiration_date":"2031-11-05","underlying":"Common Stock","underlying_shares":8045},"source":{"system":"sec-edgar","filing":"0001628280-21-022605","document":"wf-form4_163649706826161.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021022605/wf-form4_163649706826161.xml","form_type":"4"}},{"id":2520640,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":48456,"kind":"person","name":"ACKERMAN JOEL","position":1,"cik":"0001220630","reported_name":"ACKERMAN JOEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-11-09T22:30:30.000Z","date":"2021-11-05","kind":"grant","acquired":true,"shares":18564,"price":10.1,"value":187496.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2021,  February 5, 2022, May 5, 2022 and August 5, 2022, respectively."}],"balance_after":18564,"derivative":{"exercise_price":10.1,"expiration_date":"2031-11-05","underlying":"Common Stock","underlying_shares":18564},"source":{"system":"sec-edgar","filing":"0001628280-21-022604","document":"wf-form4_163649701340351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021022604/wf-form4_163649701340351.xml","form_type":"4"}},{"id":2520641,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":37734,"kind":"person","name":"TOBIN SCOTT R","position":1,"cik":"0001199926","reported_name":"TOBIN SCOTT R","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-11-09T22:29:46.000Z","date":"2021-11-05","kind":"grant","acquired":true,"shares":14851,"price":10.1,"value":149995.1,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2021,  February 5, 2022, May 5, 2022 and August 5, 2022, respectively."}],"balance_after":14851,"derivative":{"exercise_price":10.1,"expiration_date":"2031-11-05","underlying":"Common Stock","underlying_shares":14851},"source":{"system":"sec-edgar","filing":"0001628280-21-022603","document":"wf-form4_163649697182669.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021022603/wf-form4_163649697182669.xml","form_type":"4"}},{"id":2540019,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-10-19T19:39:48.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2016, February 1, 2017, May 1, 2017 and August 1, 2017, respectively."}],"balance_after":0,"derivative":{"exercise_price":1.59,"expiration_date":"2021-11-01","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001628280-21-020221","document":"wf-form4_163467237424646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021020221/wf-form4_163467237424646.xml","form_type":"4"}},{"id":2540018,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-19T19:39:48.000Z","date":"2021-10-15","kind":"tax_withholding","acquired":true,"shares":2629,"price":10.08,"value":26500.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"net exercise\" of outstanding stock options. The shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on October 15, 2021."}],"balance_after":762272,"source":{"system":"sec-edgar","filing":"0001628280-21-020221","document":"wf-form4_163467237424646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021020221/wf-form4_163467237424646.xml","form_type":"4"}},{"id":2540017,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-19T19:39:48.000Z","date":"2021-10-15","kind":"exercise","acquired":true,"shares":16667,"price":1.59,"value":26500.53,"ownership":{"direct":true},"balance_after":764901,"source":{"system":"sec-edgar","filing":"0001628280-21-020221","document":"wf-form4_163467237424646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021020221/wf-form4_163467237424646.xml","form_type":"4"}},{"id":2544010,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":37734,"kind":"person","name":"TOBIN SCOTT R","position":1,"cik":"0001199926","reported_name":"TOBIN SCOTT R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-10-13T14:26:00.000Z","date":"2021-10-12","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested"}],"balance_after":0,"derivative":{"exercise_price":1.59,"expiration_date":"2021-11-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-21-009382","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000117911021009382/edgar.xml","form_type":"4"}},{"id":2544009,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":37734,"kind":"person","name":"TOBIN SCOTT R","position":1,"cik":"0001199926","reported_name":"TOBIN SCOTT R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-13T14:26:00.000Z","date":"2021-10-12","kind":"exercise","acquired":true,"shares":10000,"price":1.59,"value":15900.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001179110-21-009382","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000117911021009382/edgar.xml","form_type":"4"}},{"id":2772523,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73486,"kind":"person","name":"Breitfeld Philip P.","position":1,"cik":"0001690133","reported_name":"Breitfeld Philip P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-03-25T19:27:04.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":4167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and are exercisable over a four month period, with vesting to occur on May 1, 2016 and August 1, 2016, respectively."}],"balance_after":0,"derivative":{"exercise_price":3.65,"expiration_date":"2021-04-11","underlying":"Common Stock","underlying_shares":4167},"source":{"system":"sec-edgar","filing":"0001628280-21-005610","document":"wf-form4_161670040991722.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021005610/wf-form4_161670040991722.xml","form_type":"4"}},{"id":2772522,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73486,"kind":"person","name":"Breitfeld Philip P.","position":1,"cik":"0001690133","reported_name":"Breitfeld Philip P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T19:27:04.000Z","date":"2021-03-23","kind":"tax_withholding","acquired":false,"shares":1340,"price":11.35,"value":15209.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"net exercise\" of outstanding stock options. These shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on March 23, 2021."}],"balance_after":2827,"source":{"system":"sec-edgar","filing":"0001628280-21-005610","document":"wf-form4_161670040991722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021005610/wf-form4_161670040991722.xml","form_type":"4"}},{"id":2772521,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73486,"kind":"person","name":"Breitfeld Philip P.","position":1,"cik":"0001690133","reported_name":"Breitfeld Philip P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T19:27:04.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":4167,"price":3.65,"value":15209.55,"ownership":{"direct":true},"balance_after":4167,"source":{"system":"sec-edgar","filing":"0001628280-21-005610","document":"wf-form4_161670040991722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021005610/wf-form4_161670040991722.xml","form_type":"4"}},{"id":2875678,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":142985,"kind":"person","name":"Poliakoff Abba David","position":1,"cik":"0001423066","reported_name":"Poliakoff Abba David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-02-08T21:46:30.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 4, 2019, February 4, 2020, May 4, 2020 and August 4, 2020, respectively."}],"balance_after":0,"derivative":{"exercise_price":5.43,"expiration_date":"2024-11-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-21-001615","document":"wf-form4_161282076952132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021001615/wf-form4_161282076952132.xml","form_type":"4"}},{"id":2875677,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":142985,"kind":"person","name":"Poliakoff Abba David","position":1,"cik":"0001423066","reported_name":"Poliakoff Abba David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-02-08T21:46:30.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2017, February 1, 2018, May 1, 2018 and August 1, 2018, respectively."}],"balance_after":0,"derivative":{"exercise_price":3.21,"expiration_date":"2022-10-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-21-001615","document":"wf-form4_161282076952132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021001615/wf-form4_161282076952132.xml","form_type":"4"}},{"id":2875676,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":142985,"kind":"person","name":"Poliakoff Abba David","position":1,"cik":"0001423066","reported_name":"Poliakoff Abba David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-02-08T21:46:30.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2016, February 1, 2017, May 1, 2017 and August 1, 2017 respectively."}],"balance_after":0,"derivative":{"exercise_price":1.59,"expiration_date":"2021-11-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-21-001615","document":"wf-form4_161282076952132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021001615/wf-form4_161282076952132.xml","form_type":"4"}},{"id":2875675,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":142985,"kind":"person","name":"Poliakoff Abba David","position":1,"cik":"0001423066","reported_name":"Poliakoff Abba David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-08T21:46:30.000Z","date":"2021-01-19","kind":"tax_withholding","acquired":true,"shares":8873,"price":11.53,"value":102305.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"net exercise\" of outstanding stock options. The shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on January 19,2021."}],"balance_after":81274,"source":{"system":"sec-edgar","filing":"0001628280-21-001615","document":"wf-form4_161282076952132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021001615/wf-form4_161282076952132.xml","form_type":"4"}},{"id":2875674,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":142985,"kind":"person","name":"Poliakoff Abba David","position":1,"cik":"0001423066","reported_name":"Poliakoff Abba David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-08T21:46:30.000Z","date":"2021-01-19","kind":"exercise","acquired":true,"shares":10000,"price":5.43,"value":54300.0,"ownership":{"direct":true},"balance_after":90147,"source":{"system":"sec-edgar","filing":"0001628280-21-001615","document":"wf-form4_161282076952132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021001615/wf-form4_161282076952132.xml","form_type":"4"}},{"id":2875673,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":142985,"kind":"person","name":"Poliakoff Abba David","position":1,"cik":"0001423066","reported_name":"Poliakoff Abba David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-08T21:46:30.000Z","date":"2021-01-19","kind":"exercise","acquired":true,"shares":10000,"price":3.21,"value":32100.0,"ownership":{"direct":true},"balance_after":80147,"source":{"system":"sec-edgar","filing":"0001628280-21-001615","document":"wf-form4_161282076952132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021001615/wf-form4_161282076952132.xml","form_type":"4"}},{"id":2875672,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":142985,"kind":"person","name":"Poliakoff Abba David","position":1,"cik":"0001423066","reported_name":"Poliakoff Abba David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-08T21:46:30.000Z","date":"2021-01-19","kind":"exercise","acquired":true,"shares":10000,"price":1.59,"value":15900.0,"ownership":{"direct":true},"balance_after":70147,"source":{"system":"sec-edgar","filing":"0001628280-21-001615","document":"wf-form4_161282076952132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021001615/wf-form4_161282076952132.xml","form_type":"4"}},{"id":2941267,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73486,"kind":"person","name":"Breitfeld Philip P.","position":1,"cik":"0001690133","reported_name":"Breitfeld Philip P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-17T14:29:29.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":31443,"price":11.3531,"value":356975.5233,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-20-017581","document":"wf-form4_160821535638533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020017581/wf-form4_160821535638533.xml","form_type":"4"}}],"next_cursor":"2020-12-17T14:29:29.000000Z,2941267"}